The announcement

Warpaint London (LSE:W7L) said on Friday 13 November 2026 that its nominated adviser would now act as its sole broker. The short notice gave no reason for the change. Earlier filings, including the completion of its share buyback on 25 September, listed a second joint broker alongside its nominated adviser, so the effect is that the company has moved from two Brokers to one.

A broker change does not alter the Business itself. It can, however, affect how a company is covered by analysts, how its shares are marketed to institutions and who handles any future Buybacks or placings. Its nominated adviser executed the £2.5m buyback that the company (LSE:W7L) completed in September.

Background on the buyback and register

That programme, which began on 27 July 2026, repurchased 1,189,575 shares at a weighted average of £2.101 each, all placed in treasury. After completion the company (LSE:W7L) had 80,787,321 shares in issue and 79,597,746 voting rights. It was described at the interim stage as an initial programme; no further buyback has been announced since.

A concentrated customer base

The more substantive issue for a smaller broker roster to explain to investors is customer concentration. In the six months to 30 June 2026, the group's top ten customers, excluding direct online sales, accounted for 68% of revenue, up from 65% a year earlier, according to the interim results published on 23 September.

Several of the period's swings came from individual accounts. The company said UK sales fell 15.8% to £15.2m partly because Bodycare, a major Technic customer, entered administration in September 2025. Rest of the world sales dropped to £1.2m from £3.6m because a large Australian customer had ordered heavily late in 2025, and the company said that customer has since resumed regular ordering. US sales fell 24.3% to £1.8m, against a prior period helped by a significant Five Below order before tariffs rose.

On the positive side, the company pointed to growth with Superdrug, an additional 200 Tesco Express stores, a W7 launch into 2,200 Rossmann stores in Germany that met the retailer's pilot metrics, and a substantially larger Christmas order from Walmart. The Acquisition of Barry M in February, which contributed £2.5m of sales, was explained partly as a way to deepen the Superdrug relationship.

Why it matters

The same concentration that allows a large order to transform a half-year can equally remove a slice of Revenue when a retailer fails or changes its ordering pattern. Group revenue for the half fell 17.8% to £40.5m, and much of the explanation offered by the company related to specific customers rather than broad demand. Direct online sales, which spread risk more widely, were 8.9% of the total.

Brand concentration adds to the picture. W7 produced £23.9m, or 59% of group revenue, in the half, down from £29.8m, while Technic sales fell to £8.7m from £12.4m after the loss of Bodycare. Europe accounted for 55% of sales. A group this reliant on one Brand and a handful of retailers relies on keeping those relationships, which is where clear investor communication counts.

Factors to watch

The company does not name its largest customers' individual shares of revenue. Retailer insolvencies on the high street remain a risk, and US trade remains affected by tariffs. The board guided in September that 2026 revenue would be towards the lower end of analyst forecasts of £103.3m to £112.6m, with adjusted EBITDA within the £22.4m to £24.0m range. Those are analysts' numbers, which the company said it does not endorse.

Next dates

The 4.25p Interim Dividend is due for payment on 20 November 2026. The company has not yet announced a date for its full-year trading update or results for the year to 31 December 2026.